# Intensive Adjuvant Therapy for TNBC with BRCA Gene Mutation

> **NCT06405295** · — · ENROLLING_BY_INVITATION · sponsor: **Cancer Institute and Hospital, Chinese Academy of Medical Sciences** · enrollment: 600 (estimated)

## Conditions studied

- Breast Carcinoma
- BRCA Mutation
- Adjuvant Drug Therapy

## Interventions

- **OTHER:** no intervention

## Key facts

- **NCT ID:** NCT06405295
- **Lead sponsor:** Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2024-05-06
- **Primary completion:** 2029-03-01
- **Final completion:** 2029-05-01
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2025-02-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06405295

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06405295, "Intensive Adjuvant Therapy for TNBC with BRCA Gene Mutation". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06405295. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*